logo

SONM

DNA X·NASDAQ
--
--(--)
--
--(--)

SONM fundamentals

DNA X (SONM) released its earnings on Oct 31, 2025: revenue was 16.21M (YoY +7.94%), missed estimates; EPS was -4.83 (YoY +48.40%), missed estimates.
Revenue / YoY
16.21M
+7.94%
EPS / YoY
-4.83
+48.40%
Report date
Oct 31, 2025
EPS
Revenue

Revenue & Expenses

SONM has released its 2025 Q3 earnings report, with revenue of 16.21M, reflecting a YoY change of 7.94%, and net profit of -4.75M, showing a YoY change of -89.21%. The Sankey diagram below clearly presents SONM's revenue sources and cost distribution.

Key Indicators

DNA X (SONM) key financial stats and ratios, covering profitability, financial health, and leverage.
DNA X (SONM)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
DNA X (SONM)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
DNA X (SONM)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does DNA X (SONM) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track DNA X (SONM) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield